Patients, researchers and clinicians…
increasing our knowledge of lobular breast cancer
working together to advance diagnosis, treatment and follow-up care for patients

LBCA advocates for ILC research and educates about lobular breast disease

Join Us: Subscribe for News and Updates

About Lobular Breast Cancer

Invasive lobular breast cancer (ILC) is the sixth most frequently diagnosed cancer of women in the US with 39,000 new patients diagnosed each year.  

Research indicates that ILC is a unique histological subtype of breast cancer with distinct biological and behavioral differences. It’s time to advance research and refine treatments for patients with lobular breast disease.

HELP US REACH OUR GOALS

Learn about Research Advocacy

A research advocate has an interest in the science behind breast cancer research.  Research advocates help breast cancer research reflect patient needs.

Share Information about ILC

Advocates and allies can raise awareness about lobular breast cancer in your local cancer community and educate others about the disease.

Advocacy Opportunities

Contact LBCA to find out about advocacy opportunities such as participating in events and conferences, sharing information at your local cancer center or organization, hosting an event … or share your ideas.

Fundraise or Donate

Tax-deductible donations will fund LBCA’s work to advance research, build partnerships and educate about Lobular Breast Cancer.

Advance ILC Research

  • Research Priorities identified by Lobular Breast Cancer patient advocates...

  • The ROLO trial is a targeted therapy clinical trial in the United Kingdom for patients with advanced or metastatic lobular breast cancer. Name of the trial: ROLO– A phase 2 study for advanced lo...

  • The GELATO clinical trial is a lobular breast-cancer specific immunotherapy trial investigating the response to an immunotherapy + chemotherapy medication combination. This phase 2 trial is open to me...

  • Women who have been diagnosed with Stage 1 - 3 invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a clinical trial.  This trial i...

  • Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a multi-site clinical trial....

  • Patients with Metastatic Lobular Breast Cancer (cancer has spread beyond the breast to other parts of the body) have a unique opportunity to advance critical research by participating in the Metastati...

  • Clinical Trials Improve Patient Care and Outcomes and advance critical research to improve our understanding of Invasive Lobular Breast Cancer...

RESOURCE LIBRARY

News + Events

MEET PATIENTS WITH ILC

LBCA does not administer, moderate or review the content posted in these social media groups or the Hotline.

LBCA IS PLEASED TO PARTNER WITH THESE ORGANIZATIONS

SHARE for women facing breast or ovarian cancer